← Leaderboards
Philip Andrew Vieira
California State Univ-Dominguez Hills
$422,200
Attributed
$422,200
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $142.3K · FY2019–21$200K$150K$100K$50K$0
'19
'20
'21
Funding mix
By agency
NIH$422,200 · 1
By mechanism
SC2$422,200 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Drug Targeting”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Susan Abushakra · Alzheon, Inc.$47,265,244
- John Damon Chodera · Sloan-Kettering Inst Can Research$38,850,978
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
Research focus
Drug TargetingAptamerDrug MetabolismDrug Of AbuseBiosensing TechniquesBiosensorAddictionAwakeBaseDrug MonitoringClinically RelevantCocaineCollaborationsCommunitiesBlood - Brain Barrier AnatomyAnimal ModelDoseDoxorubicinDrug AbuseBrainCaliforniaDrug EfficacyDrug KineticsDrug Usage
Grant awards (3)
High precision pharmacokinetic measurements in brain using a novel aptamer-based biosensor$142,300
SC2 · FY2021 · GM · contact PI
High precision pharmacokinetic measurements in brain using a novel aptamer-based biosensor$142,300
SC2 · FY2020 · GM · contact PI
High precision pharmacokinetic measurements in brain using a novel aptamer-based biosensor$137,600
SC2 · FY2019 · GM · contact PI